Albireo Pharma IncのSMA 50
Albireo Pharma IncのSMA 50は何ですか。
Albireo Pharma IncのSMA 50は$44 -0.41%です。
SMA 50の定義は何ですか。
SMA 50は、過去50日間の終値の非加重平均として計算された過去50日間の平均株価である。
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NASDAQのセクタHealth CareにおけるSMA 50の企業と比べるAlbireo Pharma Inc
Albireo Pharma Incは何をしますか。
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma Incと類似のsma 50
- SquarespaceのSMA 50は$44 +4.40%です。
- Avidity BiosciencesのSMA 50は$44 -9.12%です。
- Magnet ForensicsのSMA 50はCAD$44 +0.00%です。
- Multi Units Luxembourg SICAV - Lyxor MSCI Emu (DR)ETFのSMA 50は€44 -Inf%です。
- Home CapitalのSMA 50はCAD$44 +0.01%です。
- Smurfit Kappa PlcのSMA 50は$44 +9.76%です。
- Albireo Pharma IncのSMA 50は$44 -0.41%です。
- BGR SystemsのSMA 50は₨44 +3.67%です。
- Topps Tiles PlcのSMA 50はGBX44 +7.12%です。
- Papa John`s InternationalのSMA 50は$44 +8.89%です。
- KBC Ancora SCAのSMA 50は€44 +3.98%です。
- Kymera TherapeuticsのSMA 50は$44 +0.79%です。
- PTL EnterprisesのSMA 50は₨44 -1.02%です。